Investors
Smith+Nephew is a portfolio medical technology company focused on the repair, regeneration and replacement of soft and hard tissue.
Quarterly Results
We have released our Q2/H1 quarter 2024 results update.
Q2 2024 Results Webcast
We released our second quarter 2024 results on Thursday 1 August 2024.
Webcast
Watch the recording of our live webcast, presented by Deepak Nath, Chief Executive Officer and John Rogers, Chief Financial Officer.
Events
The Annual General Meeting
01 May 2024Smith+Nephew Academy London, Building 5, Croxley Park, Hatters Lane, Watford, WD18 8YE
Event details:
The Annual General Meeting of Smith & Nephew plc was held at 12:00pm on Wednesday 1 May 2024 at Smith+Nephew Academy London, Building 5, Croxley Park, Hatters Lane, Watford, WD18 8YE.
Investor Resources
Sustainability
As a portfolio medical technology company, Smith+Nephew’s purpose is to restore and promote health and wellbeing.
We believe that this applies not just to the benefits our products deliver to patients, but also to the wider health of the planet and society.